ai-powered drug discovery / isomorphic labs / deepmind spinout — Topic | TechScan AI — Tech & AI News

ai-powered drug discovery / isomorphic labs / deepmind spinout

Bloomberg : Sources: Isomorphic Labs, an AI-powered drug discovery company spun out of Google DeepMind, is in advanced talks to raise $2B+ led by Thrive Capital — Isomorphic Labs, an AI-powered drug discovery company spun out of Alphabet Inc.'s Google DeepMind, is in advanced discussions to raise …

1.4

Rising

News Items

Articles

Sources

First Seen

2026-05-08 19:10:04

7-Day Trend

05-09

05-10

05-11

05-12

Source Breakdown

techmeme (2)NewsNow (1)Buzzing (1)

Key Entities

AlphabetIsomorphic Labs(Alphabet)DeepMind(Alphabet/Google)Thrive Capital

Why It Matters

Large funding for an AI drug discovery spinout signals growing investor confidence in computational biology platforms and could accelerate partnerships, talent shifts, and platform adoption across pharma and biotech.

Latest Changes

Isomorphic Labs completed a $2.1B funding round led by Thrive Capital.
This follow-on raise comes after an initial $600M round in March 2025.
Multiple outlets reported the company had been in advanced talks to raise over $2B.

Timeline

2025-03-01 — Isomorphic Labs raised an initial $600M funding round.
2026-05-08 — Bloomberg reported Isomorphic Labs was in advanced talks to raise over $2B led by Thrive.
2026-05-09 — Chinese outlets and reports reiterated plans for Isomorphic Labs to seek more than $2B.
2026-05-12 — Reuters reported Isomorphic Labs raised $2.1B led by Thrive Capital.
2026-05-12 — Additional international coverage confirmed the $2.1B raise and the company's AI drug discovery focus.

What to Watch

How Isomorphic Labs deploys the $2.1B across R&D, partnerships, and talent hiring.
Potential collaborations or licensing deals between Isomorphic Labs and pharma companies.

Dossier last updated: 2026-05-12 16:05:51

Recent News (4)

Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025 (Pritam Biswas/Reuters)

Pritam Biswas / Reuters : Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025 — Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion …

src_techmeme3h ago

DeepMind旗下分拆公司Isomorphic Labs筹集21亿美元，致力于利用人工智能研发药物

Buzzing5h ago

谷歌旗下Isomorphic Labs拟在新一轮融资中筹集逾20亿美元

Isomorphic Labs, the AI-driven drug discovery spinout from Google DeepMind, is reportedly seeking to raise over $2 billion in a new funding round. Sources say Thrive Capital, which led the company’s initial financing last year, is poised to lead this round, with Alphabet expected to participate. The planned raise would be a major vote of confidence in computational biology and AI-powered therapeutics, giving Isomorphic Labs substantial capital to accelerate drug discovery, scale operations, and compete in the biotech-tech crossover market. Large venture capital backing and continued Alphabet support signal strong investor appetite for AI-first life sciences startups and could reshape funding dynamics in the sector.